US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition
Patent 11041153 was granted and assigned to Bio-Path Holdings on June, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+316 characters)
Article
Patent abstract
Provided herein are improved delivery systems for oligonucleotides, said delivery system comprising a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide, which targets a STAT3-encoding polynucleotide. Methods of treating patients with said delivery systems are also provided.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Ana Tari Ashizawa0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110411530
Date of Patent
June 22, 2021
0Patent Application Number
166064190
Date Filed
April 19, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11041153
Date of patent
June 22, 2021
Patent application number
16606419
Date Filed
April 19, 2018
Patent primary examiner
Find more entities like US Patent 11041153 P-ethoxy nucleic acids for STAT3 inhibition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
